Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

which reported in March 2024 that—in a trial of more than 3,500 people with type 2 diabetes—Ozempic lowered the risk of kidney disease progression and death from kidney or cardiovascular ...

It's unclear if Ozempic can treat kidney disease in patients without diabetes. The benefit may have come from the secondary effects of weight loss and improved metabolic control. Participants in the ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama ... was made following a clinical trial of more than 3,500 people where ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

about a third of adults with diabetes also have chronic kidney disease, according to the U.S. Centers for Disease Control and Prevention. The clinical trial tested the efficacy of Ozempic when ...